Full Length Research Paper
References
|
African Union (2022) |
|
|
Bhattacharya S, Heidler P, Varshney S (2023). Incorporating neglected non-communicable diseases into the national health program-A review. Frontiers in Public Health 10:1093170. |
|
|
Budreviciute A, Damiati S, Sabir DK, Onder K, Plakys G, Katileviciute A, Kodzius R (2020). Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Frontiers in Public Health 8:574111. |
|
|
Boutayeb A (2010). The Burden of Communicable and Non-Communicable Diseases in Developing Countries. In Handbook of Disease Burdens and Quality of Life Measures pp. 531-546. |
|
|
Camara A, Baldé NM, Diakité M, Sylla D, Baldé EH, Kengne AP, Baldé MD (2016). High prevalence, low awareness, treatment and control rates of hypertension in Guinea: results from a population-based STEPS survey. Journal of Human Hypertension 30(4):237-244. |
|
|
Cheza A, Tlou B, Zhou DT (2021). Incidence of non-communicable diseases (NCDs) in HIV patients on ART in a developing country: Case of Zimbabwe's Chitungwiza Central Hospital-A retrospective cohort study (2010-2019). PLoS One 16(5):e0252180. |
|
|
Divala OH, Amberbir A, Ismail Z, Beyene T, Garone D, Pfaff C, van Oosterhout JJ (2016). The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. BMC Public Health 16:1-11. |
|
|
Ekrikpo UE, Akpan EE, Ekott JU, Bello AK, Okpechi IG, Kengne AP. (2018). Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study. BMJ Open 8(7):e019664. |
|
|
Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine 25(12):1822-1832. |
|
|
HIV info. (n.d.). HIV and Diabetes. |
|
|
Idris IO, Oguntade AS, Mensah EA, Kitamura N (2020). Prevalence of non-communicable diseases and its risk factors among Ijegun-Isheri Osun residents in Lagos State, Nigeria: a community based cross-sectional study. BMC Public Health 20 :1-10. |
|
|
Joint United Nations Programme on HIV/AIDS. (n.d.). Guinea. |
|
|
Joint United Nations Programme on HIV/AIDS. (2023). Global HIV statistics. |
|
|
Juma K, Juma PA, Shumba C, Otieno P, Asiki G (2019). Non-communicable diseases and urbanization in African cities: a narrative review. Public health in developing countries-Challenges and opportunities 15:31-50. |
|
|
Kansiime S, Mwesigire D, Mugerwa H (2019). Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda. PLoS One 14(8):e0221022. |
|
|
McCombe G, Murtagh S, Lazarus JV, Van Hout MC, Bachmann M, Jaffar S, Cullen W (2021). Integrating diabetes, hypertension and HIV care in sub-Saharan Africa: a Delphconsensus study on international best practice. BMC Health Services Research 21(1):1235. |
|
|
Mudie K, Jin MM, Kendall L, Addo J, dos-Santos-Silva I, Quint J, Perel P (2019). Non-communicable diseases in sub-Saharan Africa: a scoping review of large cohort studies. Journal of Global Health 9(2). |
|
|
National Cancer Institute (n.d.). HIV/AIDS Cancer Match Study. |
|
|
NCD Alliance (2023). Integrated care for people living with HIV, diabetes and hypertension in sub-Saharan Africa. |
|
|
Nou E, Lo J, Grinspoon SK (2016). Inflammation, immune activation, and cardiovascular disease in HIV. AIDS 30(10):1495-509. |
|
|
Odunyemi A, Rahman T, Alam K (2023). Economic burden of non-communicable diseases on households in Nigeria: evidence from the Nigeria living standard survey 2018-19. BMC Public Health 23(1):1563. |
|
|
Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe V V, Peprah E, Vorkoper S, Pastakia SD, Rausch D, Levitt NS, NIH HIV/NCD Project Disease Condition Technical Operating Group. (2018). Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS 32:S5-S20. |
|
|
Sahay S, Reddy KS, Dhayarkar S (2011). Optimizing adherence to antiretroviral therapy. Indian Journal of Medical Research 134(6):835-49. |
|
|
World Bank (n.d.). Cause of death, by non-communicable diseases (% of total) - Guinea. Retrieved from https://data.worldbank.org/indicator/SH.DTH.NCOM.ZS?locations=GN |
|
|
World Bank. (2024). Antiretroviral therapy coverage (% of people living with HIV) - Guinea. Retrieved from https://data.worldbank.org/indicator/SH.HIV.ARTC.ZS?locations=GN |
|
|
World Health Organization (WHO) (2023). Noncommunicable diseases. |
|
|
World Health Organization Regional Office for Africa (2020). Nigeria re-commits to eradicating Tuberculosis and controlling Noncommunicable Diseases by 2030. |
|
|
Webel AR, Schexnayder J, Cioe PA, Zuñiga JA (2021). A review of chronic comorbidities in adults living with HIV: state of the science. Journal of the Association of Nurses in AIDS Care 32(3):322-346. |
|
|
Wu Fan WF, Guo Yan Fei GY, Somnath Chatterji SC, Zheng Yang ZY, Naidoo N, Jiang Yong JY, Kowal P (2015). Common risk factors for chronic non-communicable diseases among older adults in China, Ghana, Mexico, India, Russia and South Africa: the study on global AGEing and adult health (SAGE) wave 1.. |
|
|
Yang Z, Zhu Z, Lizarondo L, Xing W, Han S, Hu H, Hu Y, Wu B (2021) Experience of chronic noncommunicable disease in people living with HIV: a systematic review and meta-aggregation of qualitative studies. BMC Public Health 21:1-9. |
|
|
Zaid D, Greenman Y (2019). Human Immunodeficiency Virus Infection and the Endocrine System. Endocrinology and Metabolism 34(2):95-105. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
